A long-read RNA sequencing atlas of 144 paired tumor-normal samples across ten organs shows that gene expression changes ...

A large-scale re-annotation of the Aspergillus fumigatus genome reveals that many presumed pathogen-specific genes are ...

Entrada Therapeutics is rated Buy with a $8.50 fair value, offering ~52% upside from $5.61, driven by potential validation of ...

Stanford Medicine researchers and collaborators developed an RNA-based urine test that could improve bladder cancer diagnosis ...

A team of biochemists at the University of Minnesota (UMN) accidentally discovered that a single bacterial DNA repair gene ...

PCR™ with AutoNorm intelligent normalization technology for next‑generation sequencing (NGS) library preparation, today announced new and expanded distribution partnerships that significantly increase ...

Most of any gains (or lack thereof) from here will be driven by just three factors.

Urine cell-free (cf)RNA analysis could represent a promising biomarker for bladder cancer, according to a study published online Oct. 2 in Nature Medicine. Kevin J. Liu, PhD, from Stanford University ...

Maintaining healthy blood glucose levels involves striking a balance between the glucose produced by the liver during fasting ...

A study found the AidaBREAST test can assess 10-year recurrence risk and predict radiation therapy benefit in early-stage ...

Multiomics analysis combines data from two or more omics layers—such as genomics, transcriptomics, proteomics, and ...

Larger dogs show stronger age-related DNA changes around LINE1 elements, but their role in shortening lifespan remains ...